Monkeypox Vaccine Market

Market Overview:

The global monkeypox vaccine market is expected to exhibit a CAGR of 14.90% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Monkeypox is a zoonotic viral disease caused by the monkeypox virus, belonging to the Orthropox genus from the Poxviridae family. It can be transmitted through close contact with an infected person’s body fluids and contaminated items, such as bedding, respiratory droplets, lesions, etc. Some of the common symptoms of monkeypox include fever, headache, rashes that last up to three weeks, sore throat, coughing, and enlarged lymph nodes. Lesions, which typically appear one to three days after the commencement of a fever, last for around two to four weeks and are frequently characterized as painful until they begin to itch during the healing process.

Monkeypox Vaccine Market Trends:

The rising cases of monkeypox, resulting in the declaration of a public health emergency by WHO, are primarily driving the global monkeypox vaccine market. In line with this, the growing incidences of various chronic ailments and dermatology-related problems like eczema, which results in weak immunity and higher chances of getting infected with the monkeypox virus, are also propelling the product demand. Moreover, the increasing investments in extensive R&D activities by the government authorities for the introduction of novel monkeypox vaccines are further bolstering the market growth. For instance, the UK Health Security Agency (UKHSA) and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) will receive funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to support the development of laboratory tools for evaluating monkeypox vaccines. Additionally, several government organizations are also launching favorable initiatives to spread awareness regarding disease prevention as well as the importance of immunization among the masses, especially in the endemic and rural regions. Besides this, the escalating utilization of genomic sequencing, which elucidates the specific infection-causing sequences and aid in the development of effective treatments, is expected to drive the global monkeypox vaccine market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global monkeypox vaccine market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, route of administration, distribution channel and end user.

Breakup by Type:

• Replication-competent
• Replication-deficient
   

Breakup by Route of Administration:

• Subcutaneous
• Percutaneous
   

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
   

Breakup by End User:

• Hospitals
• Clinics
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Key Questions Answered in This Report:

• How has the global monkeypox vaccine market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global monkeypox vaccine market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the route of administration?
• What is the breakup of the market based on the distribution channel?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global monkeypox vaccine market and who are the key players?
• What is the degree of competition in the industry?